Cinclus: reaches agreement with the EMA on the PIP
Cinclus Pharma has secured an agreement with the EMA Paediatric Committee (PDCO) on their Paediatric Investigation Plan (PIP) for linaprazan glurate, a necessary step toward obtaining marketing approval for adult use in the EU. A PIP outlines the approach for studying new medications in paediatric
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.